Amoneta Diagnostics - Amoneta DiagnosticsAmoneta DiagnosticsAmoneta Diagnostics

  • Products
    • APO-Easy®
    • NeuroDeGene®
    • MemoryLinc®
    • NeuroLINCs
  • Projects
  • About Us
  • News & Events
  • Contact Us

Tag: Medical

Amoneta Diagnostics > News & Events > Medical
ctad
Posted on October 22, 2024October 22, 2024 Tags Conference, Innovation, Medical, Neurology, Products

Amoneta at CTAD 2024: Introducing our Research on Advancing Alzheimer’s Disease Stratification

We are excited to announce that our team will not only be attending but also presenting at the 2024 Clinical Trials on Alzheimer's...
Read More
Posted on December 18, 2023March 7, 2024 Tags Medical, Neurology

Amoneta Diagnostics and AD Data Initiative announce ADDIA Data on AD Workbench

Huningue, France, December 12, 2023Together, Amoneta Diagnostics and the AD Data Initiative announce a collaboration to make data...
Read More

Tags

Business Conference Innovation Medical Neurology Products

Recent Posts

  • Amoneta Diagnostics at AD/PD™ 2025: APO-Easy® Genotyping kit in the Context of New Therapies’ LaunchMarch 27, 2025
  • “Meet&Match” BiovalleyOur CEO speaks on Gender and Genetics at “Meet&Match” event in StrasbourgDecember 9, 2024
Empowering clinicians, healthcare professionals, and drug developers with innovative biomarkers for precise characterization of patients with neurodegenerative disorders.
Contact us
Know more about us

Products

  • APO-Easy®
  • NeuroDeGene®
  • MemoryLinc®
  • NeuroLINCs

useful links

  • Products
  • Projects
  • About Us
  • News & Events
  • Contact Us

RECENT POSTS

  • Amoneta Diagnostics at AD/PD™ 2025: APO-Easy® Genotyping kit in the Context of New Therapies’ LaunchMarch 27, 2025
  • “Meet&Match” BiovalleyOur CEO speaks on Gender and Genetics at “Meet&Match” event in StrasbourgDecember 9, 2024
Copyright © 2025 Amoneta Diagnostics. All rights reserved.